Hasnain Faheem
SEC CIK 1352620 · EDGAR
BoughtSold
Most active insiders at GOSS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Smith Robert Paul JR | Chief Commercial Off | — | — |
| 2 | Aranda Richard | Chief Medical Off | — | — |
| 3 | Peterson Caryn | EVP, Regulatory Affairs | — | — |
| 4 | Giraudo Bryan | COO, CFO | — | — |
| 5 | Christian Waage | EVP, Tech Ops, Admin | — | — |
| 6 | Hasnain Faheem | Pres, CEO, Dir | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-05 | 2026-01-02 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | Pres, CEO, Dir | A - Grant | $0.00 | +280.0K | 837.8K | +50% | $0 |
| 2025-12-10 | 2025-12-09 | KURA | Kura Oncology, Inc. | Hasnain Faheem | Dir | M - OptEx | $3.12 | +10.0K | 34.0K | +42% | +$31.2K | |
| 2025-12-10 | 2025-12-09 | KURA | Kura Oncology, Inc. | Hasnain Faheem | Dir | S - Sale+OE | $10.98 | -10.0K | 24.0K | -29% | -$109.8K | |
| 2025-10-02 | 2025-10-01 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | Pres, CEO, Dir | A - Grant | $0.00 | +437.5K | 557.8K | +364% | $0 | |
| 2025-03-24 | 2025-03-21 | KURA | Kura Oncology, Inc. | Hasnain Faheem | Dir | M - OptEx | $6.32 | +22.7K | 46.7K | +95% | +$143.4K | |
| 2025-03-24 | 2025-03-21 | KURA | Kura Oncology, Inc. | Hasnain Faheem | Dir | S - Sale+OE | $8.00 | -22.7K | 24.0K | -49% | -$181.5K | |
| I | 2024-06-24 | 2024-06-21 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | Pres, CEO, Dir | P - Purchase | $0.67 | +372.0K | 5.41M | +7% | +$249.2K |
| 2024-03-28 | 2024-03-27 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | Pres, CEO, Dir | S - Sale | $1.16 | -23.2K | 120.3K | -16% | -$26.9K | |
| DI | 2023-07-26 | 2023-07-24 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | Pres, CEO, Dir | A - Grant | $1.82 | +540.2K | 5.04M | +12% | +$983.1K |
| DMI | 2023-03-22 | 2023-03-20+ | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | Pres, CEO, Dir | P - Purchase | $1.14 | +878.6K | 4.50M | +24% | +$999.2K |
| I | 2022-07-15 | 2022-07-15 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | Pres, CEO, Dir | P - Purchase | $7.21 | +138.7K | 3.62M | +4% | +$1000.0K |
| 2022-03-24 | 2022-03-23 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | Pres, CEO, Dir | S - Sale | $8.92 | -19.0K | 143.5K | -12% | -$169.8K |
Purchase Sale Sale after option exercise All abbreviations